Facebook Instagram X-twitter Linkedin

Ipamorelin (10mg)

Table of Contents

  • Quickstart Highlights

Ipamorelin (10mg) protocols focus on this selective growth hormone secretagogue peptide that stimulates the release of endogenous growth hormone (GH) by acting on the ghrelin receptor (GHS-R1a). Compared to earlier secretagogues, Ipamorelin is known for its relatively targeted GH release with minimal impact on cortisol or prolactin. This guide outlines a subcutaneous administration approach optimized for the 10 mg vial format.

  • Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL concentration
  • Typical daily range: 100–300 mcg per dose (subcutaneous)
  • Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg (0.05 mg) on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks
  • Protocol Overview

Concise summary of the subcutaneous regimen.

  • Goal: Support natural growth hormone release for recovery, fat metabolism, and tissue repair
  • Schedule: 1–3 injections daily, depending on protocol goals
  • Dose Range: 100–300 mcg per dose
  • Timing: Often used before sleep or in a fasted state for optimal GH pulsation support
  • Dosing Protocol

Suggested approach for the 10 mg vial format.

  • Start: 100 mcg once daily to assess tolerance
  • Target: 200–300 mcg per dose
  • Frequency: 1–3 times per day (subcutaneous)
  • Vial Duration: One 10 mg vial lasts approximately 30–100 doses, depending on protocol
  • Timing: Commonly pre-bed; alternatively, fasted morning or post-training
  • Mechanism of Action

Ipamorelin is a selective growth hormone secretagogue that binds to the ghrelin receptor (GHS-R1a) in the pituitary and hypothalamus. This binding stimulates the natural pulsatile release of growth hormone without significantly affecting cortisol, acetylcholine, or prolactin levels.

The increased growth hormone release can indirectly raise IGF-1 levels in the liver, contributing to downstream anabolic and regenerative effects such as improved protein synthesis, fat metabolism, tissue repair, and recovery. Due to its selectivity, Ipamorelin is often considered a “cleaner” GH-releasing peptide compared to earlier secretagogues.

  • Potential Benefits & Side Effects

Observations based on preclinical and clinical research contexts.

Potential Benefits:

  • May support fat loss via enhanced growth hormone release
  • May improve recovery from training and injury
  • May support lean muscle maintenance and body composition
  • May enhance sleep quality in some users

Possible Side Effects:

  • Mild water retention or temporary bloating
  • Transient fatigue or headache in some cases
  • Injection-site irritation
  • Long-term effects are still under study; they are not fully established for non-medical use